With the analysis among 6,641 patents, we discovered top 475 key players by total patent application. Chugai Pharmaceutical Co., Ltd., Axsome Therapeutics, Inc., Eli Lilly & Co. are dominant in this area. They take 9.28% of the total patent filing.
Chugai Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 289
Axsome Therapeutics, Inc.
New York, United States
Patent: 200
Indiana, United States
Patent: 127
California, United States
Patent: 84
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 81
Basel-Stadt, Switzerland
Patent: 77
Shenzhen Tajirui Biomedical Co. Ltd.
Guangdong Sheng, China
Patent: 73
New York, United States
Patent: 72
F. Hoffmann-La Roche Ltd.
With the analysis among 260 patents, we discovered top 37 start-ups by total patent application. Shenzhen Tajirui Biomedical Co. Ltd., Cipherome, Inc., Protomer Technologies, Inc. are active in this area.
Shenzhen Tajirui Biomedical Co. Ltd.
Guangdong Sheng, China
Patent: 73
California, United States
Patent: 18
Protomer Technologies, Inc.
California, United States
Patent: 13
Chengdu Hyperway Pharmaceuticals Co., Ltd.
Sichuan Sheng, China
Patent: 11
Trutino Biosciences, Inc.
California, United States
Patent: 11
Hovedstaden, Denmark
Patent: 11
Gyeonggi-do, South Korea
Patent: 10
Massachusetts, United States
Patent: 8
Minnesota, United States
Patent: 7
With the analysis among related 2,671 patents applied in the last 5 years. We discover 500 most active companies in this area. The fast-growing Axsome Therapeutics, Inc., Chugai Pharmaceutical Co., Ltd., Hinova Pharmaceuticals, Inc. take 9.96% of patent filing during this period.
Axsome Therapeutics, Inc.
New York, United States
Patent: 178
Chugai Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 48
Hinova Pharmaceuticals, Inc.
Sichuan Sheng, China
Patent: 40
Shenzhen Tajirui Biomedical Co. Ltd.
Guangdong Sheng, China
Patent: 40
Aargau, Switzerland
Patent: 35
Indiana, United States
Patent: 34
Ticino, Switzerland
Patent: 32
California, United States
Patent: 27
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Shanghai Shi, China
Patent: 25
F. Hoffmann-La Roche Ltd.
With the analysis among related 2,671 patents in last 5 years, we discover 323 new entrants. Tillotts Pharma AG, Sintetica SA, Taiwan Liposome Co., Ltd. are the most active new entrants in this area.
Aargau, Switzerland
Patent: 35
Ticino, Switzerland
Patent: 32
Taiwan Liposome Co., Ltd.
Taiwan Province, China
Patent: 21
TLC Biopharmaceuticals, Inc.
California, United States
Patent: 18
California, United States
Patent: 18
Zhejiang Tongkang Medicine Co Ltd
Zhejiang Sheng, China
Patent: 16
Arkansas, United States
Patent: 16
New York, United States
Patent: 16
Shanghai Xunhe Pharmaceutical Technology Co Ltd
Shanghai Shi, China
Patent: 15
California, United States
Patent: 15
With the analysis among 974 patents, we discovered top 206 universities and scientific research institutions by total patent application. Shanghai Institute of Materia Medica Chinese Academy of Sciences, Massachusetts Institute of Technology, China Pharmaceutical University are dominant in this area. They take 11.60% of the total patent filing.
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Shanghai Shi, China
Patent: 46
Massachusetts Institute of Technology
Massachusetts, United States
Patent: 34
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 33
President & Fellows of Harvard College
Massachusetts, United States
Patent: 21
New York, United States
Patent: 16
Arkansas, United States
Patent: 16
Beijing Shi, China
Patent: 11
Shenyang Pharmaceutical University
Liaoning Sheng, China
Patent: 11
The Johns Hopkins University
Central Region, Singapore
Patent: 10